Susquehanna International Group
BRTX icon

Susquehanna International Group’s BioRestorative Therapies BRTX Stock Holding History

Susquehanna International Group’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.04K Buy
+803
New +$4.7K ﹤0.01% 13176
2024
Q4 		– Sell
-639
Closed -$22.2K – 12223
2024
Q3 		$22.2K Buy
+639
New +$21.1K ﹤0.01% 11608

Other funds holding BRTX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Susquehanna International Group's BRTX Position: Q2 2026 in Review

Susquehanna International Group opened a new position in BioRestorative Therapies (BRTX) in Q2 2026: 803 shares worth $6.04K. The stake represents ﹤0.01% of the portfolio and ranks #13176 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in BRTX as recently as Q3 2024.

Susquehanna International Group first reported a position in BRTX in Q3 2024 and has held it in 2 quarters since. The position peaked at $22.2K in Q3 2024. 18 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • Susquehanna International Group held 803 shares of BioRestorative Therapies worth $6.04K as of Q2 2026.
  • BioRestorative Therapies was a new Susquehanna International Group position in Q2 2026.
  • BioRestorative Therapies made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13176 holding.
  • Susquehanna International Group first reported a position in BioRestorative Therapies in Q3 2024 and has held it in 2 quarters since.
  • Susquehanna International Group's BioRestorative Therapies position peaked at $22.2K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.